Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Gottlieb Joins HHS Transition Team; Will Next Stop Be FDA?

Executive Summary

Former US FDA, CMS official has been among those thought to be in the running for Trump's FDA commissioner nomination.

You may also be interested in...

Califf Sets Departure From US FDA; Ostroff May Become Interim Leader

As FDA Commissioner Robert Califf prepares to step down from his post to make way for a Trump administration replacement, former Acting Commissioner Stephen Ostroff may step into the breach.

Possible Trump FDA Commish Candidate Favors (Much) Lighter Touch

The Trump transition team is considering Jim O'Neill, a Silicon Valley investment manager, to head US FDA, according to news reports. Previous comments from O'Neill – who has some HHS experience – suggest, he favors substantially reducing FDA's role in assessing product effectiveness. While some experts are highly skeptical about O'Neill, others suggest he could champion much-needed change at the agency.

FDA Appears Close To Beginning Trump Transition Process

With HHS and CMS leaders nominated, President-elect Trump’s team now may move to US FDA evaluation, commissioner candidates.

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts